Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
NCT01972568
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
306
Enrollment
INDUSTRY
Sponsor class
Conditions
Lupus Erythematosus, Systemic
Interventions
DRUG:
Atacicept 75 milligram (mg)
DRUG:
Atacicept 150 mg
DRUG:
Placebo
Sponsor
EMD Serono